DeutschNewstral
Article
bizjournals.com on 2015-03-03 22:20
Dendreon lays off 77 including CEO W. Thomas Amick
Related news
Buyer of Dendreon lays off 77 Seattle employeesold.seattletimes.com- Valeant Pharmaceuticals approved to buy Dendreon for $495 millionbizjournals.com
- Dendreon says 2014 wasn't all horrible newsbizjournals.com
- Valeant Pharmaceuticals to bid for Dendreon cancer drug in bankruptcy auctionbizjournals.com
- Former Dendreon CEO's new biotech Alpine Immune Sciences raises $1.3Mbizjournals.com
- Why ex-Dendreon CEO's new biotech startup could succeed where Dendreon failedbizjournals.com
- Dendreon extends deadline to see if anyone wants to buy the companybizjournals.com
- Valeant Pharmaceuticals appears to be top Dendreon assets bidder at $400Mbizjournals.com
Valeant wins Dendreon with $400M bidseattletimes.com- Biotech investor explains why Juno Therapeutics won't be like Dendreonbizjournals.com
- T#77thestranger.com
Judge Clears Way for Dendreon to Auction Provengewsj.com
Houston AmickGwinnett Daily Post- Valeant in Deal to Buy Provenge From Dendreonwsj.com
- Valeant Approved to Buy Dendreon Assets for $495 Millionwsj.com
- BCarol W. Place, 77bridgton.com
Enterprise Holdings lays off 77 in Stratfordwestfaironline.com
Michael “Mike” W. Bell, 77Austin Daily Herald
Time for action on guns, including a crackdown on those already barred from owning guns: Burt W. Griffin (Opinion)cleveland.com- Former Dendreon CEO, Amgen scientists team up on new immunotherapy startupbizjournals.com